Drug recall D-0564-2024
Product
Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03
Reason for recall
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Lots and codes
Lot#: HJ3965; Exp 2024/09 Lot#: HJ8546; Exp 2024/10
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 84,710 cartridges
- Distribution
- US Nationwide and Puerto Rico.
- Type
- Voluntary: Firm initiated
- Recall initiated
- May 20, 2024
Related products
- Buprenorphine Hydrochloride – drug information
- NDC 0409-2012 Buprenorphine Hydrochloride · Buprenorphine Hydrochloride .3 mg/mL · Hospira, Inc.